Advertisement

Далерон C джуниър

Основна информация

  • Търговско наименование:
  • Далерон C джуниър (Daleron C junior)
  • Предлага се от:
  • KRKA, d.d. Novo Mesto
  • дозиране:
  • 10
  • Лекарствена форма:
  • гранули за перорален разтвор
  • Композиция:
  • гранули за перорален разтвор x 10
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици
Advertisement

Документи

Локализация

  • Предлага се в:
  • Далерон C джуниър (Daleron C junior)
    България
  • Език:
  • български

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Последна актуализация:
  • 09-08-2016

Листовка за пациента


27-2-2014

Paracetamol use during pregnancy

Paracetamol use during pregnancy

A new Danish study suggests a possible connection between mothers' use of paracetamol painkillers during pregnancy and the risk of developing disorders like ADHD (attention deficit hyperactivity disorder) in children.

Danish Medicines Agency

3-8-2012

Danish Pharmacovigilance Update, 21 June 2012

Danish Pharmacovigilance Update, 21 June 2012

Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.

Danish Medicines Agency

15-12-2017

News and press releases:  Modified-release paracetamol-containing products to be suspended from EU market

News and press releases: Modified-release paracetamol-containing products to be suspended from EU market

Recommendation endorsed due to the difficulty in managing overdose

Europe - EMA - European Medicines Agency

8-8-2017

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb)

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb)

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb) (Active substance: paracetamol / ibuprofen) - Community Referrals - Art 29 - Commission Decision (2017) 5646 of Tue, 08 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1447

Europe -DG Health and Food Safety

28-7-2017

Scientific guideline:  Draft paracetamol oral use, immediate release formulations product-specific bioequivalence guidance - First version, draft: consultation open

Scientific guideline: Draft paracetamol oral use, immediate release formulations product-specific bioequivalence guidance - First version, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol

Europe - EMA - European Medicines Agency

Advertisement